EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version | Comments | Email this article

Dispatch

Spotted-Fever Group Rickettsia in Dermacentor variabilis, Maryland

Nicole C. Ammerman,* Katherine I. Swanson,* Jennifer M. Anderson,* Timothy R. Schwartz,* Eric C. Seaberg,* Gregory E. Glass,* and Douglas E. Norris*
*Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

Suggested citation for this article: Ammerman NC, Swanson KI, Anderson JM, Schwartz TR, Seaberg EC, Glass GE, et al. Spotted-fever group Rickettsia in Dermacentor variabilis, Maryland. Emerg Infect Dis [serial on the Internet]. 2004 Aug [date cited]. Available from: http://www.cdc.gov/ncidod/EID/vol10no8/03-0882.htm

Three-hundred ninety-two adult Dermacentor variabilis were collected from six Maryland counties during the spring, summer, and fall of 2002. Infection prevalence for spotted fever group Rickettsia was 3.8%, as determined by polymerase chain reaction. Single strand conformational polymorphism (SSCP) analysis followed by sequencing indicated that all infections represented a single rickettsial taxon, Rickettsia montanensis.

The Study

Several species of spotted fever group (SFG) rickettsiae have been isolated from ticks in the United States; however, the only species considered to cause human disease in Maryland is Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever (RMSF). The potential pathogenicity of rickettsial organisms is most often predicted by the ability of the species to cause disease in guinea pigs. The reliability of this method has been debated, and researchers have suggested that "every rickettsial species may have pathogenic potential, provided that its reservoir arthropod is capable of biting humans" (1,2).

The prevalence of SFG Rickettsia infection in Dermacentor variabilis, the primary vector of R. rickettsii in the eastern United States, has been estimated in several studies. Prevalences from 0.2% in Ohio (3) to 8.6% in Maryland (4) have been reported. Many studies have implied that these infections were R. rickettsii, but few have confirmed these identities (5). Numerous SFG-rickettsial species have been isolated or partially characterized from molecular evidence in the eastern United States; these species include R. rickettsii, R. rhipicephali, R. montanensis (=R. montana), R. parkeri, and "R. amblyommi" (3,6–8). These species have been identified, either together or separately, in areas where RMSF is endemic. As the distributions of different SFG-species in disease-endemic areas become better understood, determining the relationship between the rickettsiae involved in human disease and those isolated from vector ticks and mammal and tick reservoirs may be necessary.

Differentiating the tick-borne SFG Rickettsia before the 1990s depended largely on culture and epitope recognition techniques, such as immunoflourescence and agglutination tests and mouse serotyping with monoclonal antibodies. Genotypic studies of rickettsiae conducted during the 1990s led to two rickettsial genes that can be used to identify rickettsial infections: citrate synthase (gltA) and rOmpA (9). Citrate synthase encodes the first enzyme of the tricarboxylic acid cycle and is highly conserved among all Rickettsia species, serving as a polymerase chain reaction (PCR) target to identify any rickettsial infection. rOmpA encodes a surface-expressed protein of SFG-rickettsiae that is important for adhesion to host cells (10). Only SFG Rickettsia contain the rOmpA gene (11), making it an ideal PCR target to identify SFG Rickettsia infections.

Approximately 35 cases of RMSF are reported annually in Maryland. From 1994 through 1998, Maryland ranked 8th nationally, reporting 112 cases. These cases, confirmed by the Maryland Department of Health and Mental Hygiene, meet the Centers for Disease Control and Prevention (CDC) case definition, yet not much information exists to characterize the infection rate of SFG rickettsiae in D. variabilis in the state. This cross-sectional study examined the prevalence and composition of SFG Rickettsia in D. variabilis in Maryland.

In 2002, genomic DNA was extracted from 392 adult D. variabilis collected by flagging in Anne Arundel, Baltimore, Calvert, Charles, Prince George's, and St. Mary's Counties, Maryland. Quality of the modified hexadecyltrimethylammonium bromide (CTAB) DNA extractions was verified by amplifying a tick 16S mtDNA fragment (12). Modifying the existing extraction procedure involved an additional phenol:chloroform:isoamyl alcohol (25:24:1) extraction step to further stabilize the extracted DNA. Tick extractions were screened by PCR for evidence of infection with Rickettsia by using primers specific to the Rickettsia citrate synthase gene (9). The Rickettsia infection rate was 6.1% (24/392, 95% confidence interval [CI] 4.0%–9.0%). All Rickettsia-positive tick extractions were subsequently screened by PCR for SFG Rickettsia by using primers for the rOmpA gene of SFG-Rickettsia (9). The prevalence of SFG Rickettsia infection was 3.8% (15/392, 95% CI 2.2%–6.2%). Single strand conformational polymorphism (SSCP) banding patterns were identical for all tick-derived rOmpA PCR amplicons. Similarly, SSCP banding patterns of the tick-derived citrate synthase amplicons for the SFG-Rickettsia–positive samples were monomorphic. These results suggest that these tick infections represent a single SFG Rickettsia taxon (13). Citrate synthase and rOmpA PCR products from three ticks were sequenced with the citrate synthase and shortened rOmpA PCR primers, respectively. Sequences of each respective gene fragment derived from these ticks were identical and confirm the SSCP findings (GenBank accession no.: gltA, AY548828–AY548830, rOmpA, AY543681–AY543683). The derived sequences were also compared to rickettsiae sequences in the public domain and were identical to those derived from R. montanensis from D. andersoni (GenBank accession no. RMU55823 rOmpA and RMU74756 gltA).

Prevalence estimates were reported as percentages with exact 95% CI based on the binomial distribution. Fisher exact test was used to compare infection prevalence across the strata of selected characteristics. The association between each characteristic and the prevalence of infection was quantified as odds ratios (OR), calculated with logistic regression or exact methods for categorical data when the data were highly unbalanced. All statistical analyses were performed with STATA (version 7.0; Stata Corporation, College Station, TX) or StatXact (version 5.0.3; Cytel Software Corporation, Cambridge, MA).

The variation in prevalence of Rickettsia-positive ticks across all counties was marginally significant (p = 0.052), with a higher prevalence in St. Mary's County compared to all other counties (OR 5.1, 95% CI 0.5–27.2, p value = 0.08). However, only 13 ticks were collected from St. Mary's County, so this estimate was based on limited data. In contrast to the equivocal results for the geographic distribution of Rickettsia-positive ticks, temporal heterogeneity was evident, as the prevalence of Rickettsia-positive ticks varied significantly with month of collection (p = 0.007). Risk for infection was significantly elevated for any Rickettsia organism in ticks collected in July or August (OR 4.1, 95% CI 1.5–11.5) compared to those collected in April. Further analyses combining the data from the spring and early summer months showed that the risk for infection with any Rickettsia organism in July or August was even higher (OR 4.7, 95% CI 2.0–11.3). The risk for infection with R. montanensis with the late summer months, compared to the spring and early summer months, was somewhat less but still approached statistical significance (OR 3.0, 95% CI  0.8–10.2, p value = 0.06). This observation may be an artifact of diminishing tick abundance later in the summer months.

Conclusions

The prevalence of SFG Rickettsia in D. variabilis estimated from this study (3.8%) was lower than that in previous reports from Maryland. However, in regions where RMSF is observed annually, prevalence estimates range widely, from 2% in Connecticut to 10% in Alabama, with intermediate prevalences in New York, Kentucky, Tennessee, and Arkansas (5). In addition, R. montanensis had not been previously recognized in Maryland. Most earlier studies of SFG Rickettsia infection prevalence did not identify the Rickettsia to the species level, although the SFG-positive samples were sometimes assumed to represent R. rickettsii. One study in Maryland in which 26 Rickettsia isolates were obtained from D. variabilis determined the species composition of the rickettsiae. Two isolates were R. rickettsii, 1 isolate was R. bellii (non-SFG), and 23 (88%) were identified as WB-8-2, a then-unnamed SFG-Rickettsia (5). Weller et al. performed a phylogenetic analysis and found WB-8-2 ("R. amblyommii") to be closely related to R. montanensis (14), although they can be differentiated by serotyping.

R. montanensis has been isolated from ticks in other eastern states. During the 1980s, Feng et al. reported that R. montanensis represented 41 (91%) of 45 of the SFG isolates from D. variabilis collected in Cape Cod, Massachusetts (7). Anderson et al. reported isolation of R. montanensis from D. variabilis in Connecticut (6), and in 1990, Pretzman et al. reported that most SFG Rickettsia isolated from Dermacentor ticks throughout Ohio was R. montanensis (3). Further, these researchers noted that R. rickettsii were not isolated from ticks collected in several Ohio counties where RMSF was considered endemic. These studies illustrate that the rickettsial composition and dynamics within the RMSF-endemic areas are complex and need to be addressed with greater scrutiny.

The role of SFG Rickettsia in human health is largely unknown, and many are considered to be nonpathogenic either because the bacteria have not been isolated from humans or they do not demonstrate pathogenicity in animal models. For example, R. montanensis is avirulent in guinea pigs but virulent in voles (15). These findings have led to caution when labeling rickettsiae as nonpathogenic (2). R. montanensis and other "nonpathogenic" SFG Rickettsia–infected ticks may also benefit human health by decreasing R. rickettsii in tick populations as a result of the "interference" phenomenon (15).

The findings of this study and others raise important questions. In 2000, a total of 495 cases of RMSF were reported to CDC and 4 deaths were attributed to spotted fever caused by Rickettsia rickettsii. The extent to which R. rickettsii is the agent responsible for reported cases of RMSF should be reevaluated, considering the number of studies completed in RMSF-endemic regions, including this one, that have found non–R. rickettsii as the predominant or only detectable SFG Rickettsia.

This research was supported in part by a Cooperative Agreement Award to D.E.N. (U50/CCU319554) and NIEHS training awards (T32ES07141) to J.M.A. and K.I.S.

Ms. Ammerman recently completed her Sc.M. in epidemiology at Johns Hopkins Bloomberg School of Public Health. She is continuing her research activities as a research assistant in the Department of Epidemiology before applying to a Ph.D. program.

References

1. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997;10:694–719.
2. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol. 1997;35:2715–27.
3. Pretzman C, Daugherty N, Poetter K, Ralph D. The distribution and dynamics of rickettsia in the tick population of Ohio. Ann NY Acad Sci. 1990;590:227–336.
4. Schriefer ME, Azad AF. Changing ecology of Rocky Mountain spotted fever. In: Sonenshine DE, Mather TN, editors. Ecological dynamics of tick-borne zoonoses. New York: Oxford University Press; 1994. p. 314–26.
5. Azad AF, Beard CB. Rickettsial pathogens and their arthropod vectors. Emerg Infect Dis. 1998;4:179–86.
6. Anderson JF, Magnarelli LA, Philip RN, Burgdorfer W. Rickettsia rickettsii and Rickettsia montana from Ixodid ticks in Connecticut. Am J Trop Med Hyg. 1986;35:187–91.
7. Feng WC, Murray ES, Burgdorfer W, Spielman JM, Rosenberg G, Dang K, et al. Spotted fever group rickettsiae in Dermacentor variabilis from Cape Cod, Massachusetts. Am J Trop Med Hyg. 1980;29:691–4.
8. Goddard J, Sumner JW, Nicholson WL, Paddock CD, Shen J, Piesman J. Survey of ticks collected in Mississippi for Rickettsia, Ehrlichia, and Borrelia species. J Vector Ecol. 2003;28:184–9.
9. Regnery RL, Spruill CL, Plikaytis BD. Genotypic identification of rickettsiae and estimation of intraspecies divergence for portions of two rickettsial genes. J Bacteriol. 1991;173:1576–89.
10. Li H, Walker DH. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog. 1998;24:289–98.
11. Bouyer DH, Stenos J, Crocquet-Valdes P, Moron CG, Popov VL, Zavala-Velazquez JE, et al. Rickettsia felis: molecular characterization of a new member of the spotted fever group. Int J Syst Evol Microbiol. 2001;51:339–47.
12. Norris DE, Klompen JSH, Black WC IV. Comparison of the mitochondrial 12S and 16S ribosomal DNA genes in resolving phylogenetic relationships among hard ticks (Acari: Ixodidae). Ann Entomol Soc Am. 1999;92:117–29.
13. Norris DE, Johnson BJB, Piesman J, Maupin GO, Clark JL, Black IV WC. Culturing selects for specific genotypes of Borrelia burgdorferi in an enzootic cycle in Colorado. J Clin Microbiol. 1997;35:2359–64.
14. Weller SJ, Baldridge GD, Munderloh UG, Noda H, Simser J, Kurtti TJ. Phylogenetic placement of rickettsiae from the ticks Amblyomma americanum and Ixodes scapularis. J Clin Microbiol. 1998;36:1305–17.
15. Burgdorfer W, Hayes SF, Mavros AJ. Nonpathogenic rickettsiae in Dermacentor andersoni: a limiting factor for the distribution of Rickettsia rickettsii. In: Burgdorfer W, Anacker RL, editors. Rickettsiae and rickettsial diseases. New York: Academic Press; 1981. p. 585–94.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted July 2, 2004
This page last reviewed July 22, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention